LEADER 00816nam0-22003011i-450- 001 990001144350403321 035 $a000114435 035 $aFED01000114435 035 $a(Aleph)000114435FED01 035 $a000114435 100 $a20000920d1967----km-y0itay50------ba 101 0 $aeng 200 1 $aNumerical Integration$fPhilip J. Davis, Philip Rabinowitz 210 $aWaltham [Mass.]$cBlaisdell$d1967 610 0 $aAnalisi numerica 610 0 $aIntegrazione numerica 676 $a515.624 700 1$aDavis,$bPhilip J.$f<1923- >$013883 702 1$aRabinowitz,$bPhilip 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990001144350403321 952 $a8-G-3$b7307$fMA1 959 $aMA1 962 $a65D30 996 $aNumerical Integration$9344728 997 $aUNINA DB $aING01 LEADER 01697nam 2200397 a 450 001 9910696396503321 005 20071217153136.0 035 $a(CKB)5470000002376862 035 $a(OCoLC)184739658 035 $a(EXLCZ)995470000002376862 100 $a20071217d2007 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDrug testing$b[electronic resource] $eundercover tests reveal significant vulnerabilities in DOT's drug testing program : testimony before the Subcommittee on Highways and Transit, Committee on Transportation and Infrastruture, House of Representatives /$fstatement of Gregory D. Kutz 210 1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2007] 215 $a25 pages $cdigital, PDF file 225 1 $aTestimony ;$vGAO-08-225 T 300 $aTitle from title screen (viewed on Dec. 11 2007). 300 $a"For release ... November 1, 2007." 300 $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548. 320 $aIncludes bibliographical references. 517 $aDrug testing 606 $aDrug testing$xGovernment policy$zUnited States 615 0$aDrug testing$xGovernment policy 700 $aKutz$b Gregory D$01351611 712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Transportation and Infrastructure.$bSubcommittee on Highways and Transit. 712 02$aUnited States.$bGovernment Accountability Office. 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910696396503321 996 $aDrug testing$93484066 997 $aUNINA